United States · 
Who invested in Transcarent?
Transcarent's investors include General Catalyst, Kleiner Perkins, GreatPoint Ventures, Human Capital and Geodesic Capital.
United States · Series D startup
Who invested in Transcarent
Funding summaryUpdated 26 Oct 2026
$481Mraised across 1 round since 2025, from 1 source
- Latest round
- Series D, $481MApr 2025
- Investors
- 5
TranscarentEmployee benefits1 / 15Their pitch deckTranscarent's pitch deck, 15 slidesEach slide read for what it argues, against the decks that raised at the same stage.→The rounds
- Apr 2025Series D$481M
Source recordedSEC filing: $481M sold, first sale Apr 2025
Founders and team
From Transcarent's own website: 14 on the team.
- Glen TullmanChief Executive Officer
- Laurie McGrawExecutive Vice President
- Tom RichardsExecutive Vice President, Consultant Relations & Business Development
- Anjali JamesonChief Product Officer
- Caitlin FlemingChief Strategy Officer
- Erica PalsisChief Legal Officer
- Janine GianfrediChief Marketing Officer
- Jennifer TrzepaczChief People Officer
- Kristen BruzekChief Service & Clinical Operations Officer
- Mike MorganChief Commercial Officer
- Praful KaulChief Technology Officer
- Rachel StillmanChief of Staff
- Stephanie PengChief Financial Officer
- Ken FrazierChairman of the Board
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 4 firms list Transcarent as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Transcarent
How much has Transcarent raised?
Transcarent has raised $481M across 1 round since 2025.
When did Transcarent last raise?
Transcarent's most recent round was a Series D of $481M in Apr 2025.
What was Transcarent's biggest round?
Its most recent round, $481M in Apr 2025, is also its largest on record.
Who backed Transcarent first?
Transcarent's first round on record, in Apr 2025, was backed by General Catalyst, Kleiner Perkins and GreatPoint Ventures and 2 others.
What stage is Transcarent at?
Transcarent's latest named round is a Series D, in Apr 2025.
Where is Transcarent based?
Transcarent is based in the United States.
Companies like Transcarent
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.